I thought this was interesting, but I would much prefer the medicine any of our esteemed IC Mag members grow rather than support the chemical version created in a lab. Now they'll say cannabis has real medical value, but that we need to pay for a pharmaceutical company's version rather than grow our own!
----------------------
A British pharmaceutical company was working Wednesday to develop a new breed of cannabis-based products aimed at treating a range of conditions including diabetes, epilepsy and Crohn's disease. GW Pharmaceuticals, which launched a cannabis-derived medicine for symptoms of multiple sclerosis last year, has cross-bred different types of the plant to produce a new strain that could treat a wide range of disorders.
----------------------
A British pharmaceutical company was working Wednesday to develop a new breed of cannabis-based products aimed at treating a range of conditions including diabetes, epilepsy and Crohn's disease. GW Pharmaceuticals, which launched a cannabis-derived medicine for symptoms of multiple sclerosis last year, has cross-bred different types of the plant to produce a new strain that could treat a wide range of disorders.